Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Oct-24 4:15 PM View:  | Kranzler Jay D Director | Avenue Therapeutics, Inc. (ATXI) | 30-Sep-24 | Purchase | 497 | $2.50 | $1,242.50 | 404% 0.12K to 0.62K | |
| 01-Oct-24 4:15 PM View: | Kranzler Jay D Director | Avenue Therapeutics, Inc. (ATXI) | 27-Sep-24 | Purchase | 3 | $2.40 | $7.20 | 3% 0.12K to 0.12K | |
| 25-Sep-24 4:55 PM View: | MacLean Alexandra Chief Executive Officer Director | Avenue Therapeutics, Inc. (ATXI) | 23-Sep-24 | Grant | 170,000 | -- | -- | 100% 0 to 170.0K | |
| 25-Sep-24 4:53 PM View: | Jin David Interim PFO and COO | Avenue Therapeutics, Inc. (ATXI) | 23-Sep-24 | Grant | 65,000 | -- | -- | 100% 0 to 65.0K | |
| 17-Apr-24 4:05 PM View: | Fortress Biotech, Inc. 10% Owner | Avenue Therapeutics, Inc. (ATXI) | 16-Apr-24 | Grant | 413,507 | -- | -- | 13% 3.13M to 3.55M | |
| 03-Jan-24 4:27 PM View: | Fortress Biotech, Inc. 10% Owner | Avenue Therapeutics, Inc. (ATXI) | 02-Jan-24 | Grant | 2,101,500 | -- | -- | 204% 1.03M to 3.13M | |
| 13-Dec-23 4:02 PM View: | Davidow Robert L 10% Owner | Avenue Therapeutics, Inc. (ATXI) | 11-Dec-23 | Sale | 264,000 | $0.14 | $36,960.00 | (14%) 1.84M to 1.57M | |
| 13-Dec-23 4:02 PM View: | Davidow Robert L 10% Owner | Avenue Therapeutics, Inc. (ATXI) | 11-Dec-23 | Sale | 353,000 | $0.14 | $49,600.00 | (22%) 1.57M to 1.22M | |
| 12-Sep-23 9:02 AM View: | Fortress Biotech, Inc. 10% Owner | Avenue Therapeutics, Inc. (ATXI) | 08-Sep-23 | Private Purchase | 418,410 | $0.72 | $301,255.00 | 68% 613.98K to 1.03M | |
| 12-Sep-23 9:03 AM View: | Rosenwald Lindsay A Md Director | Avenue Therapeutics, Inc. (ATXI) | 08-Sep-23 | Private Purchase | 348,675 | $0.72 | $251,046.00 | 6179% 5.64K to 354.32K | |
| 04-Apr-23 4:08 PM View: | Fortress Biotech, Inc. 10% Owner | Avenue Therapeutics, Inc. (ATXI) | 31-Mar-23 | Grant | 52,419 | -- | -- | 9% 561.56K to 613.98K | |
| 04-Jan-23 5:49 PM View: | Fortress Biotech, Inc. 10% Owner | Avenue Therapeutics, Inc. (ATXI) | 03-Jan-23 | Grant | 231,316 | -- | -- | 70% 330.25K to 561.56K | |
| 04-Jan-23 5:49 PM View: | Fortress Biotech, Inc. 10% Owner | Avenue Therapeutics, Inc. (ATXI) | 31-Dec-22 | Grant | 90,909 | -- | -- | 38% 239.34K to 330.25K | |
| 13-Oct-22 8:52 PM View: | Invagen Pharmaceuticals, Inc. 10% Owner | Avenue Therapeutics, Inc. (ATXI) | 11-Oct-22 | Private Sale | 388,888 | $7.71 | $2,999,880.00 | (100%) 388.89K to 0 | |
| 20-Dec-21 5:07 PM View: | Vazzano Joseph Walter Chief Financial Officer | Avenue Therapeutics, Inc. (ATXI) | 17-Dec-21 | Grant | 100,505 | -- | -- | 154% 65.25K to 165.76K | |
| 21-Dec-21 4:24 PM View: | Oltmans Curtis Gale Director | Avenue Therapeutics, Inc. (ATXI) | 17-Dec-21 | Grant | 49,020 | -- | -- | 100% 0 to 49.02K | |
| 21-Dec-21 4:26 PM View: | Kranzler Jay D Director | Avenue Therapeutics, Inc. (ATXI) | 17-Dec-21 | Grant | 69,020 | -- | -- | 107% 64.66K to 133.68K | |
| 21-Dec-21 4:26 PM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 17-Dec-21 | Grant | 69,020 | -- | -- | 60% 114.72K to 183.74K | |
| 20-Dec-21 5:08 PM View: | Lu Lucy President, CEO Director | Avenue Therapeutics, Inc. (ATXI) | 17-Dec-21 | Grant | 411,616 | -- | -- | 122% 337.33K to 748.95K | |
| 15-Sep-21 4:03 PM View: | Vazzano Joseph Walter Chief Financial Officer | Avenue Therapeutics, Inc. (ATXI) | 15-Sep-21 | Market Sale | 7,160 | $1.62 | $11,599.20 | (10%) 72.41K to 65.25K | (7%) |
| 07-May-21 8:02 AM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 06-May-21 | Market Purchase | 2,500 | $3.99 | $9,975.00 | 2% 132.22K to 134.72K | |
| 21-Aug-20 4:15 PM View: | Vazzano Joseph Walter Chief Financial Officer | Avenue Therapeutics, Inc. (ATXI) | 20-Aug-20 | Market Sale | 3,840 | $12.13 | $46,579.20 | (6%) 61.25K to 57.41K | 45% |
| 16-Jun-20 5:09 PM View: | Kranzler Jay D Director | Avenue Therapeutics, Inc. (ATXI) | 16-Jun-20 | Grant | 10,000 | -- | -- | 13% 74.66K to 84.66K | |
| 16-Jun-20 5:09 PM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 16-Jun-20 | Grant | 10,000 | -- | -- | 8% 122.22K to 132.22K | |
| 10-Mar-20 4:42 PM View: | Vazzano Joseph Walter Chief Financial Officer | Avenue Therapeutics, Inc. (ATXI) | 10-Mar-20 | Market Purchase | 1,889 | $7.94 | $14,998.70 | 3% 59.36K to 61.25K | (16%) |
| 10-Mar-20 4:42 PM View: | Vazzano Joseph Walter Chief Financial Officer | Avenue Therapeutics, Inc. (ATXI) | 09-Mar-20 | Market Purchase | 1,500 | $7.99 | $11,983.00 | 3% 57.86K to 59.36K | (17%) |
| 02-Mar-20 8:10 AM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 27-Feb-20 | Market Purchase | 2,400 | $8.20 | $19,680.00 | 2% 119.82K to 122.22K | (19%) |
| 02-Mar-20 8:10 AM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 26-Feb-20 | Market Purchase | 161 | $8.73 | $1,405.53 | < 1% 119.66K to 119.82K | (24%) |
| 25-Feb-20 4:53 PM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 25-Feb-20 | Market Purchase | 10,000 | $9.31 | $93,100.00 | 9% 109.66K to 119.66K | (29%) |
| 25-Feb-20 4:55 PM View: | Vazzano Joseph Walter Chief Financial Officer | Avenue Therapeutics, Inc. (ATXI) | 25-Feb-20 | Market Purchase | 1,200 | $9.09 | $10,908.00 | 2% 56.66K to 57.86K | (27%) |
| 16-Sep-19 4:16 PM View: | Ingram Elizabeth Garrett Director | Avenue Therapeutics, Inc. (ATXI) | 12-Sep-19 | Market Purchase | 16,000 | $6.27 | $100,320.00 | 100% 0 to 16.0K | 6% |
| 28-Aug-19 4:17 PM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 27-Aug-19 | Grant | 10,000 | -- | -- | 10% 99.66K to 109.66K | |
| 28-Aug-19 4:17 PM View: | Kranzler Jay D Director | Avenue Therapeutics, Inc. (ATXI) | 27-Aug-19 | Grant | 10,000 | -- | -- | 15% 64.66K to 74.66K | |
| 12-Aug-19 4:19 PM View: | Vazzano Joseph Walter Chief Financial Officer | Avenue Therapeutics, Inc. (ATXI) | 09-Aug-19 | Market Sale | 2,375 | $5.56 | $13,205.00 | (4%) 59.04K to 56.66K | (20%) |
| 12-Aug-19 4:19 PM View: | Vazzano Joseph Walter Chief Financial Officer | Avenue Therapeutics, Inc. (ATXI) | 08-Aug-19 | Market Sale | 2,313 | $5.62 | $12,999.10 | (4%) 61.35K to 59.04K | (19%) |
| 19-Jun-19 4:54 PM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 18-Jun-19 | Market Purchase | 2,000 | $5.83 | $11,660.00 | 2% 97.66K to 99.66K | 14% |
| 19-Jun-19 4:54 PM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 17-Jun-19 | Market Purchase | 3,000 | $5.88 | $17,640.00 | 3% 94.66K to 97.66K | 13% |
| 15-Apr-19 4:33 PM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 15-Apr-19 | Market Purchase | 1,000 | $4.52 | $4,520.00 | 1% 93.66K to 94.66K | 47% |
| 29-Mar-19 4:33 PM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 29-Mar-19 | Market Purchase | 1,400 | $5.11 | $7,154.00 | 2% 92.26K to 93.66K | 30% |
| 29-Mar-19 4:33 PM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 28-Mar-19 | Market Purchase | 600 | $5.11 | $3,066.00 | < 1% 91.66K to 92.26K | 30% |
| 25-Feb-19 4:13 PM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 25-Feb-19 | Market Purchase | 5,000 | $5.46 | $27,300.00 | 6% 86.66K to 91.66K | 22% |
| 06-Feb-19 4:31 PM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 05-Feb-19 | Market Purchase | 1,850 | $5.77 | $10,674.50 | 2% 84.81K to 86.66K | 15% |
| 06-Feb-19 4:31 PM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 04-Feb-19 | Market Purchase | 7,000 | $5.91 | $41,370.00 | 9% 77.81K to 84.81K | 13% |
| 01-Feb-19 12:48 PM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 30-Jan-19 | Market Purchase | 650 | $5.91 | $3,841.50 | < 1% 77.16K to 77.81K | 13% |
| 30-Jan-19 4:18 PM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 29-Jan-19 | Market Purchase | 8,553 | $5.91 | $50,548.20 | 12% 68.61K to 77.16K | 13% |
| 30-Jan-19 4:18 PM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 28-Jan-19 | Market Purchase | 1,447 | $5.84 | $8,450.48 | 2% 67.16K to 68.61K | 14% |
| 12-Dec-18 1:15 PM View: | Paley Jeffrey Director | Avenue Therapeutics, Inc. (ATXI) | 10-Dec-18 | Market Purchase | 5,000 | $4.76 | $23,800.00 | 7% 74.66K to 79.66K | 40% |
| 12-Dec-18 1:15 PM View: | Paley Jeffrey Director | Avenue Therapeutics, Inc. (ATXI) | 03-Dec-18 | Market Purchase | 10,000 | $5.48 | $54,754.00 | 15% 64.66K to 74.66K | 21% |
| 08-Aug-18 9:43 PM View: | Kranzler Jay D Director | Avenue Therapeutics, Inc. (ATXI) | 07-Aug-18 | Gift | 14,663 | -- | -- | 29% 50.0K to 64.66K | |
| 08-Aug-18 9:45 PM View: | Herskowitz Neil Director | Avenue Therapeutics, Inc. (ATXI) | 07-Aug-18 | Gift | 14,663 | -- | -- | 28% 52.5K to 67.16K |
